Details of Drug

Drug General Information (ID: D0165)
Drug Name	Benzphetamine
Drug Type	Small molecule
Drug Synonymous	Benzaphetamine; Benzfetamina; Benzfetamine; Benzfetaminum; Benzofetamina; Benzphetaminum; Benzylamphetamine; Benzfetamina [DCIT]; Benzfetamina [Spanish]; Benzfetaminum [Latin]; U 0441; Benzfetamina [INN-Spanish]; Benzfetamine (INN); Benzfetamine [INN:BAN]; Benzfetaminum [INN-Latin]; Benzofetamina [INN-Spanish]; Benzphetaminum [INN-Latin]; D-Benzphetamine; Didrex (TN); N-Benzylmethamphetamin; N-Benzyl-N,alpha-dimethylphenethylamine; N,alpha-Dimethyl-N-(phenylmethyl)benzeneethanamine; D-N-Methyl-N-benzyl-beta-phenylisopropylamine; N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine; N-Benzyl-N-methyl-1-phenyl-2-propanamine; N-benzyl-N-methyl-1-phenylpropan-2-amine; N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine; Benzeneethanamine, N,alpha-dimethyl-N-(phenylmethyl)-, (+)-(9CI); (+)-N,alpha-dimethyl-N-(phenylmethyl)-benzeneethanamine; (+)-N-benzyl-N,alpha-dimethylphenethylamine; (+)-benzphetamine; (2S)-N-benzyl-N-methyl-1-phenylpropan-2-amine; (R,S)-N-Benzyl-alpha,N-dimethylphenethylamin; (S)-(+)-N-benzyl-N,alpha-dimethylphenethylamine; (S)-(+)-benzphetamine; (S)-benzphetamine; (alphaS)-N,alpha-dimethylphenethylamine Click to Show/Hide
Disease Class	5B80-5B81: Obesity
Therapeutic Class	Cns Stimulants
Structure
Structure	3D Structure		2D Structure
Formula	C17H21N
InChI	1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1
InChIKey	YXKTVDFXDRQTKV-HNNXBMFYSA-N
Canonical SMILES	CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2
External Link
	Pubchem ID	5311017
	CAS Number	156-08-1
	CHEBI ID	3044
	TTD ID	D0T5UL
	INTEDE ID	DR0198

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM003 Affected organization distribution AM004 Affected intra/extra-hepatic metabolism AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM005 Altered gastric pH BM014 Interference of cell/tissue uptake BM017 CYP450 enzyme inhibition BM024 Competitive inhibition of metabolic enzyme BM029 Altered urine pH BM038 Additive CNS depression effects BM041 Additive hypertensive effects BM046 Additive serotonergic effects BM061 Increased risk of hyperpyrexia BM064 Increased risk of hypoglycemia BM069 Increased risk of lowers seizure threshold BM081 Increased risk of ventricular arrhythmias BM083 Potentiated the pharmacological effects (Unspecific) BM089 Antagonize the effect of antihypertensive agents BM093 Antagonize the effect of dopaminergic agents BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Benzphetamine
Affected gastrointestinal absorption
	Altered gastric pH					Drug Num: 9
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0111		Ascorbic acid	C6H8O6	54670067	Moderate		Inter Info	[49]
D0049		Aluminum hydroxide	AlH3O3	10176082	Moderate		Inter Info	[48]
D0236		Calcium carbonate	CCaO3	10112	Moderate		Inter Info	[48]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[48]
D0967		Magaldrate	AlHMgO5S+2	3086011	Moderate		Inter Info	[48]
D0968		Magnesium carbonate	CMgO3	11029	Moderate		Inter Info	[48]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[48]
D0974		Magnesium oxide	MgO	14792	Moderate		Inter Info	[48]
D0729		Glutamic acid	C5H9NO4	33032	Moderate		Inter Info	[49]
Affected organization distribution
	Interference of cell/tissue uptake					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0829		Iobenguane (I-131)	C8H10IN3	60860	Major		Inter Info	[31]
D1821		Iobenguane (I-123)	C8H10IN3	60860	Moderate		Inter Info	[123], [124], [125]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0220		Bupropion	C13H18ClNO	444	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19]
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[98], [99]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[100]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Moderate		Inter Info	[98], [99]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[113]
D0732		Glycerol phenylbutyrate	C33H38O6	10482134	Moderate		Inter Info	[20], [122]
D0899		Lefamulin	C28H45NO5S	25185057	Moderate		Inter Info	[124], [129], [130]
D0439		Delavirdine	C22H28N6O3S	5625	Moderate		Inter Info	[166]
	Competitive inhibition of metabolic enzyme					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1476		Sirolimus	C51H79NO13	5284616	Moderate		Inter Info	[161], [162]
D1549		Temsirolimus	C56H87NO16	6918289	Moderate		Inter Info	[161], [162]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[161], [162]
Affected excretion pathways
	Altered urine pH					Drug Num: 9
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0070		Ammonium chloride	ClH4N	25517	Moderate		Inter Info	[105], [49], [106]
D0886		Lactic acid	C3H6O3	612	Moderate		Inter Info	[126], [127], [128]
D1020		Methenamine	C6H12N4	4101	Moderate		Inter Info	[105], [49], [106]
D1086		Monopotassium phosphate	H2KO4P	516951	Moderate		Inter Info	[105], [49], [106]
D1319		Potassium citrate	C6H5K3O7	13344	Moderate		Inter Info	[126], [157], [105], [158], [127], [128]
D1478		Sodium acetate	C2H3NaO2	517045	Moderate		Inter Info	[126], [157], [105], [158], [127], [128]
D1480		Sodium bicarbonate	CHNaO3	516892	Moderate		Inter Info	[126], [157], [105], [158], [127], [128]
D1483		Sodium citrate	C6H5Na3O7	6224	Moderate		Inter Info	[126], [157], [105], [158], [127], [128]
D1654		Tromethamine	C4H11NO3	6503	Moderate		Inter Info	[126], [157], [105], [158], [127], [128]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0617		Ethanol	C2H6O	702	Moderate		Inter Info	[91], [112], [89]
	Additive hypertensive effects					Drug Num: 49
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0377		Cocaine (nasal)	C17H21NO4	446220	Major		Inter Info	[20], [21], [22]
D0378		Cocaine (topical)	C17H21NO4	446220	Major		Inter Info	[20], [21], [22]
D0451		Desvenlafaxine	C16H25NO2	125017	Major		Inter Info	[23], [24], [25]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[23], [24], [25]
D0600		Esketamine	C13H16ClNO	182137	Major		Inter Info	[29], [30]
D1066		Milnacipran	C15H22N2O	65833	Major		Inter Info	[23], [24], [25]
D1461		Sertraline	C17H17Cl2N	68617	Major		Inter Info	[23], [24], [25]
D1464		Sibutramine	C17H26ClN	5210	Major		Inter Info	[23], [24], [25]
D1535		Tapentadol	C14H23NO	9838022	Major		Inter Info	[23], [24], [25]
D1708		Vortioxetine	C18H22N2S	9966051	Major		Inter Info	[23], [24], [25]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[23], [24], [25]
D0539		Duloxetine	C18H19NOS	60835	Major		Inter Info	[23], [24], [25]
D0676		Fluoxetine	C17H18F3NO	3386	Major		Inter Info	[23], [24], [25]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Major		Inter Info	[23], [24], [25]
D1229		Paroxetine	C19H20FNO3	43815	Major		Inter Info	[23], [24], [25]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[95], [96], [97]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[95], [96], [97]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[50], [52], [107]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[95], [96], [97]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[95], [96], [97]
D0517		Dopamine	C8H11NO2	681	Moderate		Inter Info	[50], [52], [107]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[95], [96], [97]
D0526		Doxepin (topical)	C19H21NO	667477	Moderate		Inter Info	[95], [96], [97]
D0538		Droxidopa	C9H11NO5	92974	Moderate		Inter Info	[111]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[50], [52], [107]
D0857		Isometheptene	C9H19N	22297	Moderate		Inter Info	[50], [52], [107]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[50], [52], [107]
D0921		Levonordefrin	C9H13NO3	164739	Moderate		Inter Info	[50], [52], [107]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[50], [52], [107]
D1002		Mephentermine	C11H17N	3677	Moderate		Inter Info	[50], [52], [107]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[50], [52], [107]
D1374		Racepinephrine	C9H13NO3	838	Moderate		Inter Info	[50], [52], [107]
D1385		Rasagiline	C12H13N	3052776	Moderate		Inter Info	[37], [59], [38], [20], [61], [39], [40], [62], [42], [43], [63], [44], [64], [65], [45], [70], [46], [71], [159], [53], [54], [56], [160], [57], [58]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[50], [52], [107]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[50], [52], [107]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[50], [52], [107]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[50], [52], [107]
D0510		Dobutamine	C18H23NO3	36811	Moderate		Inter Info	[50], [52], [107]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[95], [96], [97]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[50], [52], [107]
D1013		Metaraminol	C9H13NO2	5906	Moderate		Inter Info	[50], [52], [107]
D1027		Methoxamine	C11H17NO3	6082	Moderate		Inter Info	[50], [52], [107]
D1153		Norepinephrine	C8H11NO3	439260	Moderate		Inter Info	[50], [52], [107]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[95], [96], [97]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[50], [52], [107]
D1276		Phenylephrine	C9H13NO2	6041	Moderate		Inter Info	[50], [52], [107]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[95], [96], [97]
D1363		Pseudoephedrine	C10H15NO	7028	Moderate		Inter Info	[50], [52], [107]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[95], [96], [97]
	Additive serotonergic effects					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0035		Alfentanil	C21H32N6O3	51263	Moderate		Inter Info	[92], [93], [94]
D0466		Dextromethorphan	C18H25NO	5360696	Moderate		Inter Info	[92], [93], [94]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[92], [93], [94]
D0646		Fentanyl	C22H28N2O	3345	Moderate		Inter Info	[92], [93], [94]
D1001		Meperidine	C15H21NO2	4058	Moderate		Inter Info	[92], [93], [94]
D1247		Pentazocine	C19H27NO	441278	Moderate		Inter Info	[92], [93], [94]
D1512		Sufentanil	C22H30N2O2S	41693	Moderate		Inter Info	[92], [93], [94]
	Increased risk of hyperpyrexia					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0853		Isocarboxazid	C12H13N3O2	3759	Major		Inter Info	[37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58]
D1036		Methylene blue	C16H18ClN3S	6099	Major		Inter Info	[37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[37], [59], [38], [29], [20], [60], [61], [39], [40], [62], [41], [42], [43], [63], [44], [64], [65], [66], [67], [68], [45], [69], [70], [46], [71], [72], [73], [74], [47], [48], [75], [76], [49], [50], [77], [78], [79], [51], [80], [81], [52], [82], [53], [83], [54], [55], [84], [85], [56], [57], [86], [87], [88], [58]
D1345		Procarbazine	C12H19N3O	4915	Major		Inter Info	[37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58]
D1455		Selegiline	C13H17N	26757	Major		Inter Info	[37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58]
D0933		Linezolid	C16H20FN3O4	441401	Major		Inter Info	[37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58]
D1263		Phenelzine	C8H12N2	3675	Major		Inter Info	[37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58]
D1620		Tranylcypromine	C9H11N	19493	Major		Inter Info	[37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58]
	Increased risk of hypoglycemia					Drug Num: 37
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0009		Acarbose	C25H43NO18	41774	Moderate		Inter Info	[89], [90], [91]
D0029		Albiglutide	C148H224N40O45	145994868	Moderate		Inter Info	[89], [90], [91]
D0042		Alogliptin	C18H21N5O2	11450633	Moderate		Inter Info	[89], [90], [91]
D0245		Canagliflozin	C24H25FO5S	24812758	Moderate		Inter Info	[89], [90], [91]
D0418		Dapagliflozin	C21H25ClO6	9887712	Moderate		Inter Info	[89], [90], [91]
D0565		Empagliflozin	C23H27ClO7	11949646	Moderate		Inter Info	[89], [90], [91]
D0728		Glipizide	C21H27N5O4S	3478	Moderate		Inter Info	[89], [90], [91]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[89], [90], [91]
D0807		Insulin aspart (aspart protamine)	C256H381N65O79S6	118984445	Moderate		Inter Info	[89], [90], [91]
D0808		Insulin aspart (aspart)	C256H381N65O79S6	118984445	Moderate		Inter Info	[89], [90], [91]
D0809		Insulin degludec	C274H411N65O81S6	118984462	Moderate		Inter Info	[89], [90], [91]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Moderate		Inter Info	[89], [90], [91]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Moderate		Inter Info	[89], [90], [91]
D0930		Linagliptin	C25H28N8O2	10096344	Moderate		Inter Info	[89], [90], [91]
D0936		Liraglutide	C172H265N43O51	16134956	Moderate		Inter Info	[89], [90], [91]
D0941		Lixisenatide	C215H347N61O65S	90472060	Moderate		Inter Info	[89], [90], [91]
D1294		Pioglitazone	C19H20N2O3S	4829	Moderate		Inter Info	[89], [90], [91]
D1326		Pramlintide	C171H267N51O53S2	70691388	Moderate		Inter Info	[89], [90], [91]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[89], [90], [91]
D1449		Saxagliptin	C18H25N3O2	11243969	Moderate		Inter Info	[89], [90], [91]
D1477		Sitagliptin	C16H15F6N5O	4369359	Moderate		Inter Info	[89], [90], [91]
D1603		Tolbutamide	C12H18N2O3S	5505	Moderate		Inter Info	[89], [90], [91]
D0727		Glimepiride	C24H34N4O5S	3476	Moderate		Inter Info	[89], [90], [91]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Moderate		Inter Info	[89], [90], [91]
D0813		Insulin human	C257H383N65O77S6	118984375	Moderate		Inter Info	[89], [90], [91]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Moderate		Inter Info	[89], [90], [91]
D0815		Insulin human (isophane)	C257H383N65O77S6	118984375	Moderate		Inter Info	[89], [90], [91]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Moderate		Inter Info	[89], [90], [91]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Moderate		Inter Info	[89], [90], [91]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Moderate		Inter Info	[89], [90], [91]
D0820		Insulin lispro (protamine)	C257H389N65O77S6	16132438	Moderate		Inter Info	[89], [90], [91]
D1015		Metformin	C4H11N5	4091	Moderate		Inter Info	[89], [90], [91]
D1064		Miglitol	C8H17NO5	441314	Moderate		Inter Info	[89], [90], [91]
D1112		Nateglinide	C19H27NO3	5311309	Moderate		Inter Info	[89], [90], [91]
D1429		Rosiglitazone	C18H19N3O3S	77999	Moderate		Inter Info	[89], [90], [91]
D1601		Tolazamide	C14H21N3O3S	5503	Moderate		Inter Info	[89], [90], [91]
D1652		Troglitazone	C24H27NO5S	5591	Moderate		Inter Info	[89], [90], [91]
	Increased risk of lowers seizure threshold					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0833		Iohexol	C19H26I3N3O9	3730	Major		Inter Info	[32], [33], [34], [35], [36]
D0834		Iopamidol	C17H22I3N3O8	65492	Major		Inter Info	[32], [33], [34], [35], [36]
D0054		Amifampridine	C5H7N3	5918	Moderate		Inter Info	[103], [104]
D0722		Ginkgo biloba	NA	NA	Moderate		Inter Info	[114], [115], [116], [117], [118], [119], [120], [121]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[155], [156], [20]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[155], [156], [20]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[155], [156], [20]
D0932		Lindane	C6H6Cl6	727	Moderate		Inter Info	[168], [169], [170]
	Potentiated the pharmacological effects (Unspecific)					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1577		Thyroid, porcine	NA	NA	Moderate		Inter Info	[163], [164], [165]
D0925		Levothyroxine	C15H11I4NO4	5819	Moderate		Inter Info	[163], [164], [165]
D0934		Liothyronine	C15H12I3NO4	5920	Moderate		Inter Info	[163], [164], [165]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 9
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0457		Dexfenfluramine	C12H16F3N	66265	Major		Inter Info	[26], [27], [28]
D0486		Diethylpropion	C13H19NO	7029	Major		Inter Info	[26], [27], [28]
D0952		Lorcaserin	C11H14ClN	11658860	Major		Inter Info	[26], [27], [28]
D1012		Metamfetamine	C10H15N	10836	Major		Inter Info	[26], [27], [28]
D1262		Phendimetrazine	C12H17NO	30487	Major		Inter Info	[26], [27], [28]
D0641		Fenfluramine	C12H16F3N	3337	Major		Inter Info	[26], [27], [28]
D0981		Mazindol	C16H13ClN2O	4020	Major		Inter Info	[26], [27], [28]
D1270		Phentermine	C10H15N	4771	Major		Inter Info	[26], [27], [28]
D1281		Phenylpropanolamine	C9H13NO	26934	Major		Inter Info	[26], [27], [28]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antihypertensive agents					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0444		Deserpidine	C32H38N2O8	8550	Moderate		Inter Info	[108], [109], [110]
D0744		Guanethidine	C10H22N4	3518	Moderate		Inter Info	[108], [109], [110]
D0743		Guanadrel	C10H19N3O2	38521	Moderate		Inter Info	[108], [109], [110]
	Antagonize the effect of dopaminergic agents					Drug Num: 16
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[101], [46], [102]
D1010		Mesoridazine	C21H26N2OS2	4078	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D1019		Methdilazine	C18H20N2S	14677	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D0750		Haloperidol	C21H23ClFNO2	3559	Moderate		Inter Info	[131], [132], [167], [133], [135], [136], [137], [138], [139], [101], [140], [141], [142], [143], [144], [145], [48], [53], [102], [151], [152], [153], [154]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D1355		Propiomazine	C20H24N2OS	4940	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D1572		Thiethylperazine	C22H29N3S2	5440	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D1574		Thioridazine	C21H26N2S2	5452	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[131], [132], [133], [134], [135], [136], [137], [138], [139], [101], [140], [141], [46], [142], [143], [144], [145], [48], [146], [147], [49], [89], [148], [50], [149], [51], [94], [150], [53], [102], [151], [152], [153], [154]

References
1	Canadian Pharmacists Association.
2	Dufresne RL, Weber SS, Becker RE "Bupropion hydrochloride." Drug Intell Clin Pharm 18 (1984): 957-64. [PMID: 6439541]
3	Enns MW "Seizure during combination of trimipramine and bupropion." J Clin Psychiatry 62 (2001): 476-7. [PMID: 11465529]
4	Gittelman DK, Kirby MG "A seizure following bupropion overdose." J Clin Psychiatry 54 (1993): 162. [PMID: 8486598]
5	Guzey C, Norstrom A, Spigset O "Change from the CYP2D6 extensive metabolizer to the poor metabolizer phenotype during treatment with bupropion." Ther Drug Monit 24 (2002): 436-7. [PMID: 12021638]
6	James WA, Lippmann S "Bupropion: overview and prescribing guidelines in depression." South Med J 84 (1991): 222-4. [PMID: 1899294]
7	Johnston JA, Lineberry CG, Ascher JA, et al. "A 102-center prospective study of seizure in association with bupropion." J Clin Psychiatry 52 (1991): 450-6. [PMID: 1744061]
8	Masco HL, Kiev A, Holloman LC, Batey SR, Johnston JA, Lineberry CG "Safety and efficacy of bupropion and nortriptyline in outpatients with depression." Curr Ther Res Clin Exp 55 (1994): 851-63.
9	Pisani F, Spina E, Oteri G "Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice." Epilepsia 40(Suppl 10) (1999): S48-56. [PMID: 10609604]
10	Product Information. Aplenzin (buPROPion). sanofi-aventis , Bridgewater, NJ.
11	Product Information. Wellbutrin (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
12	Product Information. Wellbutrin SR (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
13	Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
14	Product Information. Zyban (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
15	Rosenstein DL, Nelson JC, Jacobs SC "Seizures associated with antidepressants: a review." J Clin Psychiatry 54 (1993): 289-99. [PMID: 8253696]
16	Shad MU "A possible bupropion and imipramine interaction." J Clin Psychopharmacol 17 (1997): 118. [PMID: 10950476]
17	Sheehan DV, Welch JB, Fishman SM "A case of bupropion-induced seizure." J Nerv Ment Dis 174 (1986): 496-8. [PMID: 3090199]
18	Shin YW, Erm TM, Choi EJ, Kim SY "A Case of Prolonged Seizure Activity After Combined Use of Bupropion and Clomipramine." Clin Neuropharmacol 27 (2004): 192-194. [PMID: 15319707]
19	Storrow AB "Bupropion overdose and seizure." Am J Emerg Med 12 (1994): 183-4. [PMID: 8161393]
20	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
21	Thevasagyam M, Jindal M, Allsop P, Oates J "Does epinephrine infiltration in septoplasty make any difference?" Eur Arch Otorhinolaryngol 264 (2007): 1175-8.[PMID: 17530270]
22	Product Information. Cocaine Hydrochloride (cocaine topical). Mallinckrodt Medical Inc, St. Louis, MO.
23	Barrett J, Meehan O, Fahy T "SSRI and sympathomimetic interaction." Br J Psychiatry 168 (1996): 253.[PMID: 8837926]
24	Prior FH, Isbister GK, Dawson AH, Whyte IM "Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine." Med J Aust 176 (2002): 240-1.[PMID: 11999244]
25	Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. "Harrison's Principles of Internal Medicine. 14th ed." New York, NY: McGraw-Hill Health Professionals Division (1998):
26	Product Information. Meridia (sibutramine). Knoll Pharmaceutical Company, Whippany, NJ.
27	Product Information. Diethylpropion Hydrochloride SR (diethylpropion). Watson Pharmaceuticals, Parsippany, NJ.
28	Product Information. Phendimetrazine Tartrate SR (phendimetrazine). Sandoz Inc, Broomfield, CO.
29	Cerner Multum, Inc. "Australian Product Information.".
30	Product Information. Spravato (esketamine). Janssen Pharmaceuticals, Titusville, NJ.
31	Product Information. Azedra (iobenguane I-131). Progenics Pharmaceuticals, Inc., New York, NY.
32	Product Information. Isovue-M-200 (iopamidol). Bracco Diagnostics Inc, Princeton, NJ.
33	Product Information. Amipaque (metrizamide) Nycomed Inc, Princeton, NJ.
34	Hindmarsh T, Grepe A, Widen L "Metrizamide-phenothiazine interaction: report of a case with seizures following myelography." Acta Radiol Diagn (Stockh) 16 (1975): 129-35. [PMID: 810000]
35	Product Information. Omnipaque 180 (iohexol). Amersham Health, Princeton, NJ.
36	Product Information. Osmovist 240 (iotrolan). Berlex Canada Inc, Lachine, QC.
37	Ban TA "Drug interactions with psychoactive drugs." Dis Nerv Syst 36 (1975): 164-6. [PMID: 1116424]
38	Boakes AJ, Laurence DR, Teoh PC, Barar FS, Benedikter LT, Pritchard BN "Interactions between sympathomimetic amines and antidepressant agents in man." Br Med J 1 (1973): 311-5. [PMID: 4685619]
39	FISCHER E, ORLANDO J, LUDMER RL. INFLUENCIA DE METILANFETAMINA, IPRONIACIDA Y TRANILCIPROMINA SOBRE LA DEPRESI'ON PSICOMOTORA ADRENAL'INICA [EFFECT OF METHYLAMPHETAMINE, IPRONIAZID AND TRANYLCYPROMINE ON ADRENALINE PSYCHOMOTOR DEPRESSION]. Prensa Med Argent. 1964;51:1538-1540. [PMID: 14272082]
40	Darcy PF, Griffin JP "Interactions with drugs used in the treatment of depressive illness." Adverse Drug React Toxicol Rev 14 (1995): 211-31. [PMID: 8845455]
41	De Vita VT, Hahn MA, Oliverio VT "Monoamine oxidase inhibition by a new carcinostatic agent, n-isopropyl-a-(2-methylhydrazino)-p-toluamide (MIH). (30590)." Proc Soc Exp Biol Med 120 (1965): 561-5. [PMID: 4379192]
42	Elis J, Laurence DR, Mattie H, Prichard BN "Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure." Br Med J 2 (1967): 75-8. [PMID: 6020852]
43	Goldberg LI "Monoamine oxidase inhibitors: adverse reactions and possible mechanisms." JAMA 190 (1964): 456-62. [PMID: 14197995]
44	Harrison WM, McGrath PJ, Stewart JW, Quitkin F "MAOIs and hypertensive crises: the role of OTC drugs." J Clin Psychiatry 50 (1989): 64-5. [PMID: 2464583]
45	Krisko I, Lewis E, Johnson JE "Severe hyperpyrexia due to tranylcypromine-amphetamine toxicity." Ann Intern Med 70 (1969): 559-64. [PMID: 5775035]
46	Markowitz JS, Patrick KS "Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder." Clin Pharmacokinet 40 (2001): 753-72. [PMID: 11707061]
47	Pettinger WA, Soyangco FG, Oates JA "Inhibition of monoamine oxidase in man by furazolidone." Clin Pharmacol Ther 9 (1968): 442-7. [PMID: 5655478]
48	Product Information. Adderall (amphetamine-dextroamphetamine) Shire Richwood Pharmaceutical Company, Florence, KY.
49	Product Information. Dexedrine (dextroamphetamine) SmithKline Beecham, Philadelphia, PA.
50	Product Information. Focalin (dexmethylphenidate). Mikart Inc, Atlanta, GA.
51	Product Information. Ritalin (methylphenidate). Novartis Pharmaceuticals, East Hanover, NJ.
52	Product Information. Strattera (atomoxetine). Lilly, Eli and Company, Indianapolis, IN.
53	Product Information. Vyvanse (lisdexamfetamine). Shire US Inc, Florence, KY.
54	Schildkraut JJ, Klerman GL, Friend DG, Greenblatt M "Biochemical and pressor effects of oral d,l-dihydroxyphenylalanine in patients pretreated with antidepressant drugs." Ann N Y Acad Sci 107 (1963): 1005-15. [PMID: 13991689]
55	Schulz R, Antonin KH, Hoffmann E, et al "Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline." Clin Pharmacol Ther 46 (1989): 528-36. [PMID: 2510962]
56	Sjoqvist F "Psychotropic drugs (2) interaction between monoamine oxidase (MAO) inhibitors and other substances." Proc R Soc Med 58 (1965): 967-78. [PMID: 4952963]
57	Smookler S, Bermudez AJ "Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant." Ann Intern Med 11 (1982): 482-4. [PMID: 7114595]
58	Wright SP "Hazards with monoamine-oxidase inhibitors: a persistent problem." Lancet 1 (1978): 284-5. [PMID: 74715]
59	Boakes AJ, Laurence DR, Teoh PC, Barar FS, Benedikter LT, Prichard BN "Interactions between sympathomimetic amines and antidepressant agents in man." Br Med J 1 (1973): 311-5. [PMID: 4685619]
60	Coleman AL, Robin AL, Pollack IP, Rudikoff MT, Enger C, Mayer PR "Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine." Arch Ophthalmol 108 (1990): 1264-7. [PMID: 2205182]
61	Cuthbert MF, Greenberg MP, Morley SW "Cough and cold remedies: a potential danger to patients on monoamine oxidase inhibitors." Br Med J 1 (1969): 404-6. [PMID: 5763957]
62	Davies B, Bannister R, Sever P "Pressor amines and monoamine-oxidase inhibitors for treatment of postural hypotension in autonomic failure: limitations and hazards." Lancet 1 (1978): 172-5. [PMID: 74603]
63	Goulet JP, Perusse R, Turcotte JY "Contraindications to vasoconstrictors in dentistry: Part III. Pharmacologic interactions." Oral Surg Oral Med Oral Pathol 74 (1992): 692-7. [PMID: 1359489]
64	Horler AR, Wynne NA "Hypertensive crisis due to pargyline and metaraminol." Br Med J 5459 (1965): 460-1. [PMID: 14314914]
65	Humberstone PM "Hypertension from cold remedies." Br Med J 1 (1969): 846. [PMID: 5813090]
66	Hunter KR, Boakes AJ, Laurence DR, Stern GM "Monoamine oxidase inhibitors and L-dopa." Br Med J 3 (1970): 388. [PMID: 5451592]
67	King MH, Richards DW "Near syncope and chest tightness after administration of apraclonidine before argon laser iridotomy." Am J Ophthalmol 110 (1990): 308-9. [PMID: 2204271]
68	Kraft KE, Dore FH "Computerized drug interaction programs: how reliable?." JAMA 275 (1996): 1087. [PMID: 8601924]
69	Kronig MH, Roose SP, Walsh BT, Woodring S, Glassman AH "Blood pressure effects of phenelzine." J Clin Psychopharmacol 3 (1983): 307-10. [PMID: 6630590]
70	Lefebvre H, Noblet C, Morre N, Wolf LM "Pseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline." Clin Endocrinol (Oxf) 42 (1995): 95-8. [PMID: 7889639]
71	Mason AM, Buckle RM ""Cold" cures and monoamine-oxidase inhibitors." Br Med J 1 (1969): 845-6. [PMID: 5813089]
72	Nordlund JR, Pasquale LR, Robin AL, Rudikoff MT, Ordman J, Chen KS, Walt J "The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine." Arch Ophthalmol 113 (1995): 77-83. [PMID: 7826297]
73	Paykel ES "Hallucinosis on combined methyldopa and pargyline." Br Med J 1 (1966): 803. [PMID: 5910115]
74	Pekdemir M, Yanturali S, Karakus G "More than just an ocular solution." Emerg Med J 22 (2005): 753-4. [PMID: 16189050]
75	Product Information. Aldomet (methyldopa). Merck & Co, Inc, West Point, PA.
76	Product Information. Alphagan (brimonidine ophthalmic). Allergan Inc, Irvine, CA.
77	Product Information. Iopidine (apraclonidine). Alcon Laboratories Inc, Fort Worth, TX.
78	Product Information. Mirvaso (brimonidine topical). Galderma Laboratories Inc, Cranbury, NJ.
79	Product Information. Parcopa (carbidopa-levodopa). Schwarz Pharma, Mequon, WI.
80	Product Information. Sinemet (carbidopa-levodopa). DuPont Pharmaceuticals, Wilmington, DE.
81	Product Information. Stalevo 50 (carbidopa/entacapone/levodopa). Novartis Pharmaceuticals, East Hanover, NJ.
82	Product Information. Tyzine (tetrahydrozoline). Kenwood Laboratories, Fairfield, NJ.
83	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
84	Sharpe J, Marquez-Julio A, Ashby P "Idiopathic orthostatic hypotension treated with levodopa and MAO inhibitor: a preliminary report." Can Med Assoc J 107 (1972): 296-300. [PMID: 5056115]
85	Sjoerdsma A "Catecholamine-drug interactions in man." Pharmacol Rev 18 (1966): 673-83. [PMID: 5904180]
86	Teychenne PF, Calne DB, Lewis PJ, Findley LJ "Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxylase." Clin Pharmacol Ther 18 (1975): 273-7. [PMID: 1164817]
87	van Rossum JM "Potential danger of monoamineoxidase inhibitors and a-methyldopa." Lancet 1 (1963): 950-1. [PMID: 13975251]
88	van Rossum JM, Hurkmans JA "Reversal of the effect of a-Methyldopa by monamine oxidase inhibitors." J Pharm Pharmacol 15 (1963): 493-9. [PMID: 14059015]
89	Product Information. Didrex (benzphetamine) Pharmacia and Upjohn, Kalamazoo, MI.
90	Product Information. Xenical (orlistat). Roche Laboratories, Nutley, NJ.
91	Product Information. Suprenza (phentermine). Akrimax Pharmaceuticals, Cranford, NJ.
92	Gillman PK "Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity." Br J Anaesth (2005):. [PMID: 16051647]
93	Mugele J, Nanagas KA, Tormoehlen LM "Serotonin Syndrome Associated With MDPV Use: A Case Report." Ann Emerg Med (2012):. [PMID: 22237165]
94	Product Information. Sanorex (mazindol) Novartis Pharmaceuticals, East Hanover, NJ.
95	Hardman JG, Gilman AG, Limbird LE eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 9th ed." New York, NY: McGraw-Hill (1995):.
96	Haritos VS, Ghabrial H, Ahokas JT, Ching MS "Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin." Pharmacogenetics 10 (2000): 591-603. [PMID: 11037801]
97	Raisfeld IH "Cardiovascular complications of antidepressant therapy: interactions at the adrenergic neuron." Am Heart J 83 (1972): 129-33
98	Product Information. Emend (aprepitant). Merck & Company Inc, West Point, PA.
99	Product Information. Emend for Injection (fosaprepitant). Merck & Company Inc, West Point, PA.
100	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
101	Lake CR "Manic psychosis after coffee and phenylpropanolamine." Biol Psychiatry 30 (1991): 401-4. [PMID: 1912131]
102	Reid AA "Pharmacological antagonism between chlorpromazine and phenmetrazine in mental hospital patients." Med J Aust 1 (1964): 187-8. [PMID: 14126355]
103	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
104	Product Information. Firdapse (amifampridine). Catalyst Pharmaceuticals, Inc., Coral Gables, FL.
105	Beckett AH, Rowland M, Turner P "Influence of urinary pH on excretion of amphetamine." Lancet 1 (1965): 303. [PMID: 14247879]
106	Gary NE, Saidi P "Methamphetamine intoxication. A speedy new treatment." Am J Med 64 (1978): 537-40
107	Cavanaugh JH, Griffith JD, Oates JA "Effect of amphetamine on the pressor response to tyramine: formation of p-hydroxynorephedrine from amphetamine in man." Clin Pharmacol Ther 11 (1970): 656
108	Gulati OD, Dave BT, Gokhale SD, Shah KM "Antagonism of adrenergic neuron blockade in hypertensive subjects." Clin Pharmacol Ther 7 (1966): 510-4. [PMID: 5939974]
109	Gerkens JF, McCulloch MW, Wilson J "Mechanism of the antagonism between guanethidine and dexamphetamine." Br J Pharmacol 35 (1969): 563-72
110	Flegin OT, Morgan DH, Oates JA, Shand DG, Turner P "The mechanism of the reversal of the effect of guanethidine by amphetamines in cat and man." Br J Pharmacol 39 (1970): p253
111	Product Information. Northera (droxidopa). Chelsea Therapeutics Inc, Charlotte, NC.
112	Mendelson J, Jones RT, Upton R, Jacob P 3rd "Methamphetamine and ethanol interactions in humans." Clin Pharmacol Ther 57 (1995): 559-68. [PMID: 7768079]
113	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
114	Kajiyama Y, Fujii K, Takeuchi H, Manabe Y "Ginkgo seed poisoning." Pediatrics 109 (2002): 325-7. [PMID: 11826216]
115	Granger AS "Ginkgo biloba precipitating epileptic seizures." Age Ageing 30 (2001): 523-5. [PMID: 11742783]
116	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
117	Spinella M "Herbal medicines and epilepsy: the potential for benefit and adverse effects." Epilepsy Behav 2 (2001): 524-32. [PMID: 12609386]
118	Gregory PJ "Seizure associated with Ginkgo biloba?." Ann Intern Med 134 (2001): 344. [PMID: 11182853]
119	Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE "Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder." Epilepsia 47 (2006): 323-9. [PMID: 16499756]
120	Miwa H, Iijima M, Tanaka S, Mizuno Y "Generalized convulsions after consuming a large amount of Gingko nuts." Epilepsia 42 (2001): 280-1. [PMID: 11240603]
121	Kupiec T, Raj V "Fatal seizures due to potential herb-drug interactions with Ginkgo biloba." J Anal Toxicol 29 (2005): 755-8. [PMID: 16419414]
122	Product Information. Ravicti (glycerol phenylbutyrate). Hyperion Therapeutics Inc, South San Francisco, CA.
123	Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):.
124	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
125	Product Information. AdreView (iobenguane I-123). GE Healthcare, Princeton, NJ.
126	Anggard E, Jonsson LE, Hogmark AL, Gunne LM "Amphetamine metabolism in amphetamine psychosis." Clin Pharmacol Ther 14 (1973): 870-80. [PMID: 4729903]
127	Davis JM, Kopin IJ, Lemberger L, Axelrod J "Effects of urinary pH on amphetamine metabolism." Ann N Y Acad Sci 179 (1971): 493-501. [PMID: 5285389]
128	Wilkinson GR, Beckett AH "Absorption, metabolism and excretion of the ephedrines in man. I. The influence of urinary pH and urine volume output." J Pharmacol Exp Ther 162 (1968): 139-47. [PMID: 5656593]
129	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
130	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
131	Achor MB, Extein I "Diet aids, mania, and affective illness" Am J Psychiatry 138 (1981): 392. [PMID: 7468847]
132	Angrist B, Lee HK, Gershon S "The antagonism of amphetamine-induced symptomatology by a neuroleptic." Am J Psychiatry 131 (1974): 817-9. [PMID: 4600629]
133	Casey JF, Hollister LE, Klett CJ, Lasky JJ, Caffey EM "Combined drug therapy of chronic schizophrenics." Am J Psychiatry 177 (1961): 997. [PMID: 13691268]
134	Chouinard G, Ghadirian AM, Jones BD "Death attributed to ventricular arrhythmia induced by thioridazine in combination with a single Contac*C capsule." Can Med Assoc J 119 (1978): 729-31. [PMID: 709472]
135	Cornelius JR, Soloff PH, Reynolds CF, 3d "Paranoia, homicidal behavior, and seizures associated with phenylpropanolamine." Am J Psychiatry 141 (1984): 120-1. [PMID: 6691429]
136	Dewsnap P, Libby G "A case of affective psychosis after routine use of proprietary cold remedy containing phenylpropanolamine" Hum Exp Toxicol 11 (1992): 295-6. [PMID: 1354981]
137	Dietz AJ, Jr "Amphetamine-like reactions to phenylpropanolamine." JAMA 245 (1981): 601-2. [PMID: 7452888]
138	Finton CK, Barton M, Chernow B "Possible adverse effects of phenylpropanolamine (diet pills) on sympathetic nervous system function--caveat emptor!" Mil Med 147 (1982): 1072. [PMID: 6817204]
139	Grieger TA, Clayton AH, Goyer PF "Affective disorder following use of phenylpropanolamine" Am J Psychiatry 147 (1990): 367-8. [PMID: 2309957]
140	Lake CR, Tenglin R, Chernow B, Holloway HC "Psychomotor stimulant-induced mania in a genetically predisposed patient: a review of the literature and report of a case." J Clin Psychopharmacol 3 (1983): 97-100. [PMID: 6341419]
141	Lambert MT "Paranoid psychoses after abuse of proprietary cold remedies." Br J Psychiatry 151: (1987): 548-50. [PMID: 3447673]
142	Marshall RD, Douglas CJ "Phenylpropanolamine-induced psychosis: potential predisposing factors." Gen Hosp Psychiatry 16 (1994): 358-60. [PMID: 7995508]
143	Modell W, Hussar AE "Failure of dextroamphetamine sulfate to incluence eating and sleeping patterns in obese schizophrenic patients." JAMA 193 (1965): 275-8. [PMID: 14310348]
144	Mueller SM "Neurologic complications of phenylpropanolamine use." Neurology 33 (1983): 650-2. [PMID: 6682504]
145	Norvenius G, Widerlov E, Lonnerholm G "Phenylpropanolamine and mental disturbances" Lancet 2 (1979): 1367-8. [PMID: 92706]
146	Product Information. Cylert (pemoline). Abbott Pharmaceutical, Abbott Park, IL.
147	Product Information. Desoxyn (methamphetamine) Abbott Pharmaceutical, Abbott Park, IL.
148	Product Information. Fastin (phentermine). SmithKline Beecham, Philadelphia, PA.
149	Product Information. Prelu-2 (phendimetrazine) Boehringer-Ingelheim, Ridgefield, CT.
150	Product Information. Tenuate (diethylpropion) Aventis Pharmaceuticals, Swiftwater, PA.
151	Schaffer CB, Pauli MW "Psychotic reaction caused by proprietary oral diet agents." Am J Psychiatry 137 (1980): 1256-7. [PMID: 7416278]
152	Sletten IW, Ognjanov V, Menendez S, Sundland D, El-Toumi A "Weight reduction with chlorphentermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy." Curr Ther Res Clin Exp 9 (1967): 570-5. [PMID: 4965506]
153	Stroe AE, Hall J, Amin F "Psychotic episode related to phenylpropanolamine and amantadine in a healthy female." Gen Hosp Psychiatry 17 (1995): 457-8. [PMID: 8714809]
154	Wharton BK "Nasal decongestants and paranoid psychosis." Br J Psychiatry 117 (1970): 439-40. [PMID: 4098187]
155	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
156	Salik JM, Kurtin P "Severe hyponatremia after colonoscopy preparation in a patient with the acquired immune deficiency syndrome." Am J Gastroenterol 80 (1985): 177-9. [PMID: 2983533]
157	Beckett AH, Rowland M "Urinary excretion kinetics of amphetamine in man." J Pharm Pharmacol 17 (1965): 628-39. [PMID: 4379686]
158	Beckett AH, Salmon JA, Mitchard M "The relation between blood levels and urinary excretion of amphetamine under controlled acidic and under fluctuating urinary pH values using [C]amphetamine." J Pharm Pharmacol 21 (1969): 251-8. [PMID: 4390145]
159	Product Information. Azilect (rasagiline). Teva Pharmaceuticals USA, North Wales, PA.
160	Smookler S, Barmudez AJ "Hypertensive crisis resulting from an MAO inhibitor and an over-the counter appetite suppressant." Ann Emerg Med 11 (1982): 482-4. [PMID: 7114595]
161	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
162	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
163	Product Information. Armour thyroid (thyroid desiccated). Forest Pharmaceuticals, St. Louis, MO.
164	Product Information. Synthroid (levothyroxine). Abbott Pharmaceutical, Abbott Park, IL.
165	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA."
166	Product Information. Rescriptor (delavirdine). Pharmacia and Upjohn, Kalamazoo, MI.
167	Capstick C, Checkley S, Gray J, Dawe S "Dystonia induced by amphetamine and haloperidol." Br J Psychiatry 165 (1994): 276. [PMID: 7953053]
168	Matsuoka LY "Convulsions following application of gamma benzene hexachloride." J Am Acad Dermatol 5 (1981): 98-9. [PMID: 6168673]
169	Cox R, Krupnick J, Bush N, Houpt A "Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention deficit hyperactivity disorder." J Miss State Med Assoc 41 (2000): 690-2. [PMID: 10974795]
170	Product Information. Kwell (lindane). Reed and Carnrick, Jersey City, NJ.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence